Your browser doesn't support javascript.
loading
Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain - Study protocol for a randomized double-blind controlled study.
Schenker, H M; Tascilar, K; Konerth, L; Sergeeva, M; Prade, J; Strobelt, S; Kleyer, A; Simon, D; Mendez, L; Hagen, M; Schönau, V; Hueber, A; Roesch, J; Dörfler, A; Hess, A; Schett, G; Rech, J.
Afiliación
  • Schenker HM; Department of Internal Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Germany.
  • Tascilar K; Department of Internal Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Germany.
  • Konerth L; Institute of Pharmacology and Toxicology, University of Erlangen-Nuremberg, Germany.
  • Sergeeva M; Institute of Pharmacology and Toxicology, University of Erlangen-Nuremberg, Germany.
  • Prade J; Institute of Pharmacology and Toxicology, University of Erlangen-Nuremberg, Germany.
  • Strobelt S; Institute of Pharmacology and Toxicology, University of Erlangen-Nuremberg, Germany.
  • Kleyer A; Department of Internal Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Germany.
  • Simon D; Department of Internal Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Germany.
  • Mendez L; Department of Internal Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Germany.
  • Hagen M; Department of Internal Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Germany.
  • Schönau V; Department of Internal Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Germany.
  • Hueber A; Clinic Bamberg, Section Rheumatology, Bamberg, Germany.
  • Roesch J; Department of Neuroradiology, University of Erlangen-Nuremberg, Germany.
  • Dörfler A; Department of Neuroradiology, University of Erlangen-Nuremberg, Germany.
  • Hess A; Institute of Pharmacology and Toxicology, University of Erlangen-Nuremberg, Germany.
  • Schett G; Department of Internal Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Germany.
  • Rech J; Department of Internal Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Germany.
Contemp Clin Trials Commun ; 22: 100770, 2021 Jun.
Article en En | MEDLINE | ID: mdl-34041413
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Contemp Clin Trials Commun Año: 2021 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Contemp Clin Trials Commun Año: 2021 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Países Bajos